ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

KENNETH SLONE MD

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,178Medicare Part D Prescriptions Filled, Including Refills

Rank: 90 out of 1107

$989K Total Retail Price of All Prescriptions

Rank: 96 out of 1107

310 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

26% of this provider’s 310 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 12,746 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

59 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
SIMVASTATIN 747 467 1 5
LEVOTHYROXINE SODIUM 629 463 2 3
HYDROCODONE-ACETAMINOPHEN 628 433 S3 3 1
OMEPRAZOLE 494 383 4 4
FUROSEMIDE 478 371 5 7
GABAPENTIN 468 238 6 9
LISINOPRIL 434 317 7 2
AMLODIPINE BESYLATE 369 278 8 6
RANITIDINE HCL 360 235 9 21
POTASSIUM CHLORIDE 340 273 10 14
METFORMIN HCL 320 209 11 8
ATENOLOL 318 198 12 19
ATORVASTATIN CALCIUM 309 252 13 13
CITALOPRAM HBR 305 174 14 17
BENAZEPRIL HCL 291 251 15 86
METOPROLOL TARTRATE 267 210 16 10
METOPROLOL SUCCINATE 256 204 17 16
PRAVASTATIN SODIUM 248 127 18 12
CRESTOR 211 186 19 23
TRAZODONE HCL 198 140 20 33
POLYETHYLENE GLYCOL 3350 188 125 21 46
NEXIUM 187 101 22 18
HYDROCHLOROTHIAZIDE 182 140 23 11
ISOSORBIDE MONONITRATE ER 173 159 24 34
LOVAZA 163 87 25 101
FLUTICASONE PROPIONATE 162 96 26 38
COMBIVENT 145 100 27 112
AMLODIPINE BESYLATE-BENAZEPRIL 143 126 28 77
ZOLPIDEM TARTRATE 143 93 28 22
GLIPIZIDE XL 142 120 30 166
MELOXICAM 137 63 31 25
HYDROXYZINE PAMOATE 136 91 R 32 152
FLUOXETINE HCL 130 92 33 47
TRAMADOL HCL 130 82 33 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 125 78 35 24
CLOPIDOGREL 125 100 35 28
PLAVIX 123 104 37 39
DONEPEZIL HCL 122 122 38 32
NAPROXEN 117 76 39 80
SERTRALINE HCL 116 73 40 20
TAMSULOSIN HCL 114 86 41 30
METHOCARBAMOL 113 45 R 42 142
WARFARIN SODIUM 111 89 43 15
NITROSTAT 110 100 44 188
EVISTA 108 95 45 135
ALLOPURINOL 107 71 46 36
ADVAIR DISKUS 105 78 47 54
DIOVAN 102 49 48 51
CARVEDILOL 102 52 48 27
SUCRALFATE 102 67 48 121
IBUPROFEN 98 71 51 63
PROAIR HFA 98 67 51 37
SPIRONOLACTONE 96 71 53 72
LYRICA 91 61 54 83
AMITRIPTYLINE HCL 90 61 R 55 48
MISOPROSTOL 83 45 56 406
GLIMEPIRIDE 82 74 57 43
SODIUM CHLORIDE 81 76 58 186
ALENDRONATE SODIUM 81 79 58 41
PROCRIT 81 72 58 274
SINGULAIR 74 49 61 65
NAMENDA 74 74 61 42
METOCLOPRAMIDE HCL 74 50 61 116
VERAPAMIL ER 73 42 64 113
SPIRIVA 70 53 65 57
LACTULOSE 69 57 66 89
CELEBREX 69 44 66 85
PROPRANOLOL HCL 68 24 68 134
AVODART 67 56 69 204
FINASTERIDE 67 53 69 130
NYSTATIN 67 51 69 110
LIPITOR 66 63 72 109
LANSOPRAZOLE 66 45 72 102
PREDNISONE 65 47 74 40
SYMBICORT 65 35 74 124
MECLIZINE HCL 64 60 76 114
PROMETHAZINE HCL 63 37 R 77 44
JANUMET 62 46 78 197
TRIAMCINOLONE ACETONIDE 62 47 78 137
JANUVIA 61 39 80 60
PANTOPRAZOLE SODIUM 60 37 81 30
LEVOFLOXACIN 57 44 82 71
DOXEPIN HCL 55 35 83 180
RAMIPRIL 54 24 84 84
NASONEX 52 39 85 206
VENTOLIN HFA 52 40 85 97
PAROXETINE HCL 51 51 87 45
ROPINIROLE HCL 51 38 87 69
INSULIN SYRINGE 50 43 89 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 19, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.